Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Mandelker

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2016
Toward Concurrent Testing for Somatic and Germline Variants in Cancer PatientsDiana Mandelker
Science (New York, N.Y.)|January 19, 2023
Germline study points to sarcoma pathwaysDiana Mandelker, Marc Ladanyi
Advances in Anatomic Pathology|April 19, 2018
Tumor Syndromes Predisposing to OsteosarcomaMeera Hameed, Diana Mandelker
The Journal of Pathology|January 3, 2018
The emerging significance of secondary germline testing in cancer genomicsDiana Mandelker, Liying Zhang
Trends in Cancer|January 19, 2020
Evolving Significance of Tumor-Normal Sequencing in Cancer CareDiana Mandelker, Ozge Ceyhan-Birsoy
The Journal of Molecular Diagnostics : JMD|June 24, 2020
Poly (ADP Ribose) Polymerase Inhibitors for Cancer: Essential Biologic, Diagnostic, and Therapeutic Concepts for Today's PractitionerLynette M Sholl, Diana Mandelker, Tracy Stockley
JNCI Cancer Spectrum|June 30, 2020
A Clinical Approach to Detecting Germline Pathogenic Variants From Tumor-Only SequencingOzge Ceyhan-Birsoy PhD, Maksym Misyura, Diana Mandelker
Cell Cycle (Georgetown, Tex.)|April 18, 2008
Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alphaChuan-Hsiang Huang, Diana Mandelker, Sandra B Gabelli, et al.
Biochimica Et Biophysica Acta|December 8, 2009
Somatic mutations in PI3Kalpha: structural basis for enzyme activation and drug designSandra B Gabelli, Diana Mandelker, Oleg Schmidt-Kittler, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2020
Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinomaM Herman Chui, Amir Momeni Boroujeni, Diana Mandelker, et al.
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2016
Toward Concurrent Testing for Somatic and Germline Variants in Cancer PatientsDiana Mandelker
Science (New York, N.Y.)|January 19, 2023
Germline study points to sarcoma pathwaysDiana Mandelker, Marc Ladanyi
Advances in Anatomic Pathology|April 19, 2018
Tumor Syndromes Predisposing to OsteosarcomaMeera Hameed, Diana Mandelker
The Journal of Pathology|January 3, 2018
The emerging significance of secondary germline testing in cancer genomicsDiana Mandelker, Liying Zhang
Trends in Cancer|January 19, 2020
Evolving Significance of Tumor-Normal Sequencing in Cancer CareDiana Mandelker, Ozge Ceyhan-Birsoy
The Journal of Molecular Diagnostics : JMD|June 24, 2020
Poly (ADP Ribose) Polymerase Inhibitors for Cancer: Essential Biologic, Diagnostic, and Therapeutic Concepts for Today's PractitionerLynette M Sholl, Diana Mandelker, Tracy Stockley
JNCI Cancer Spectrum|June 30, 2020
A Clinical Approach to Detecting Germline Pathogenic Variants From Tumor-Only SequencingOzge Ceyhan-Birsoy PhD, Maksym Misyura, Diana Mandelker
Cell Cycle (Georgetown, Tex.)|April 18, 2008
Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alphaChuan-Hsiang Huang, Diana Mandelker, Sandra B Gabelli, et al.
Biochimica Et Biophysica Acta|December 8, 2009
Somatic mutations in PI3Kalpha: structural basis for enzyme activation and drug designSandra B Gabelli, Diana Mandelker, Oleg Schmidt-Kittler, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2020
Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinomaM Herman Chui, Amir Momeni Boroujeni, Diana Mandelker, et al.
Pageof 13